Furthermore, it is unusual that a relatively simple recurrent molecular alteration, such as bi-allelic inactivation of SMARCB1 produces a tumor with quite diverse morphologic features and clinical heterogeneity. This evidence concerns the gene SMARCB1 and neoplasm.